![Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine](https://cdn.newsserve.net/en/knowledge/Central-Drugs-Standard-Control-Organization_20181125.jpg)
Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine
An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against Covid-19 developed by Bharat Biotech, official sources said.
Full Article